Your session is about to expire
← Back to Search
White Wine for Breast Cancer
Phase < 1
Waitlist Available
Led By Kenneth Mukamal, MD, MPH
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
Study Summary
This trial is studying the effect of light alcohol consumption on sex hormones among postmenopausal women with estrogen receptor-positive (ER+) breast cancer taking an aromatase inhibitor.
Eligible Conditions
- Estrogen Receptor-positive Breast Cancer
- Breast Cancer
- Aromatase Inhibitors
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood levels of free estradiol after daily white wine
Secondary outcome measures
Blood levels of dehydroepiandrosterone sulfate (DHEAS) after daily white wine
Blood levels of estrone after daily white wine
Blood levels of sex hormone binding globulin (SHBG) after daily white wine
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: WHITE WINE FOLLOWED BY WHITE GRAPE JUICEExperimental Treatment2 Interventions
Participants will be randomized into one of the study drinking sequence groups: white wine followed by white grape juice or white grape juice followed by white wine.
The research study procedures include one screening visit to obtain informed consent, four study visits with blood draws, and ten weekly phone calls and online questionnaires over the ten weeks of the study.
-3 weeks of daily white wine followed by 3 weeks of daily white grape juice
Group II: WHITE GRAPE JUICE FOLLOWED BY WHITE WINEExperimental Treatment2 Interventions
Participants will be randomized into one of the study drinking sequence groups: white grape juice followed by white wine.
The research study procedures include one screening visit to obtain informed consent, four study visits with blood draws, and ten weekly phone calls and online questionnaires over the ten weeks of the study.
- 3 weeks of daily white grape juice followed by 3 weeks of daily white wine
Find a Location
Who is running the clinical trial?
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
806 Previous Clinical Trials
1,158,035 Total Patients Enrolled
Dana-Farber Cancer InstituteOTHER
1,080 Previous Clinical Trials
341,213 Total Patients Enrolled
141 Trials studying Breast Cancer
22,597 Patients Enrolled for Breast Cancer
Beth Israel Deaconess Medical CenterLead Sponsor
838 Previous Clinical Trials
13,010,472 Total Patients Enrolled
47 Trials studying Breast Cancer
7,245 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can drink alcohol, but only up to one drink per day.You have alcohol flushing syndrome.You don't speak or understand English.You report drinking more than one alcoholic drink per day, have a history of alcohol abuse, or have had four or more drinks in one day within the last six months.
Research Study Groups:
This trial has the following groups:- Group 1: WHITE WINE FOLLOWED BY WHITE GRAPE JUICE
- Group 2: WHITE GRAPE JUICE FOLLOWED BY WHITE WINE
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are currently engaged in this experiment?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was initiated on August 9th 2022, is now recruiting participants. In total the study requires 20 individuals from a single location to participate."
Answered by AI
Are there any applications being accepted for this clinical trial at the moment?
"Affirmative. According to clinicaltrials.gov, recruitment is currently underway for this medical trial that was originally available on August 9th 2022 and updated on September 7th 2022. The number of participants required are 20 at one particular facility."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger